These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 4454347

  • 1. [Type and incidence of side-effects during the treatment of arrhythmia with aprindin (AC 1802)].
    Breithardt G, Seipel L, Loogen F, Gleichmann U.
    Verh Dtsch Ges Inn Med; 1974; 80():1114-6. PubMed ID: 4454347
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical experiences with a new orally effective antiarrhythmic agent (Aprindin)].
    Breithardt G, Gleichmann U, Seipel L, Loogen F.
    Z Kardiol; 1974 May; 63(3):435-44. PubMed ID: 4608660
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Oral antiarrhythmic longtime therapy with aprindine (AC 1802)].
    Breithardt G, Gleichmann U, Seipel L.
    Verh Dtsch Ges Inn Med; 1973 May; 79():1001-3. PubMed ID: 4790079
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of the antiarrhythmic agent Aprindin (AC 1802) on the conductive of excitation and on the spontaneous automatics of the human heart].
    Seipel L, Gleichmann U.
    Z Kardiol; 1974 May; 63(3):426-34. PubMed ID: 4607897
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preliminary experience in the treatment of cardiac arrhythmias with aprindine.
    Bollen G, Enderle J.
    Acta Cardiol; 1974 May; Suppl 18():355-60. PubMed ID: 4138528
    [No Abstract] [Full Text] [Related]

  • 10. [Anti-arrhythmia activity and side effects of various anti-arrhythmia agents].
    Storozhuk BG.
    Vrach Delo; 1985 Mar; (3):41-4. PubMed ID: 3892899
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Pharmacokinetic characteristics and biodegradation of aprindin in man].
    Dodion L, de Suray JM, Deblecker M, Georges A.
    Therapie; 1974 Mar; 29(2):221-32. PubMed ID: 4849380
    [No Abstract] [Full Text] [Related]

  • 15. [Advantages and risks of anti-arrhythmia treatment].
    Pomerantsev VP, Gorokhovskaia GN.
    Kardiologiia; 1987 Nov; 27(11):115-7. PubMed ID: 3437657
    [No Abstract] [Full Text] [Related]

  • 16. [Drug therapy of arrhythmias during cardiostimulation and its side-effects].
    Rosol Z.
    Vnitr Lek; 1976 Dec; 22(12):1162-8. PubMed ID: 1007050
    [No Abstract] [Full Text] [Related]

  • 17. The pharmacology and clinical evaluation of aprindine a new antiarrhythmic agent.
    Fasola AF, Carmichael R.
    Acta Cardiol; 1974 Dec; Suppl 18():317-33. PubMed ID: 4138741
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.